I think when you look at the fall in sp around march as covid hit, then the rebound and rise to current levels where two lots of performance share conversions were triggered before the August deadline then it has certainly been a stunning 6 months for all involved. Well deserved and hopefully this is just the base point. We certainly are in a very strong position to go forward. Now we just need to find out if 327 "does what it says on the tin" going forward into these various trials. Huge news still to come in next 6 months.
Ann: Recce Pharmaceuticals Appoints James Graham as CEO, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.0¢ | $10.23K | 27.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3019 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 9138 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |